Reduced immunoglobulin (Ig) G response to Staphylococcus aureus in STAT3 hyper-IgE syndrome

  • Sebastian Stentzel
  • , Beate Hagl
  • , Felicitas Abel
  • , Barbara C. Kahl
  • , Anita Rack-Hoch
  • , Barbara M. Bröker
  • , Ellen D. Renner

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

STAT3 hyper-IgE syndrome (STAT3-HIES) patients presented with significantly lower Staphylococcus aureus-specific serum IgG compared to cystic fibrosis patients despite recurrent S. aureus infections. Immunoglobulin replacement therapy increased S. aureus-specific IgG in STAT3-HIES patients and attenuated the clinical course of disease suggesting a role of humoral immunity in S. aureus clearance.

Original languageEnglish
Pages (from-to)1279-1282
Number of pages4
JournalClinical Infectious Diseases
Volume64
Issue number9
DOIs
StatePublished - 1 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adaptive immunity
  • Cystic fibrosis
  • HIES
  • Hyper-IgE Syndrome
  • S. aureus
  • STAT3
  • Specific IgG
  • Th17

Fingerprint

Dive into the research topics of 'Reduced immunoglobulin (Ig) G response to Staphylococcus aureus in STAT3 hyper-IgE syndrome'. Together they form a unique fingerprint.

Cite this